Evidence map›Paper›PMID 25833289›Full record

ArticleThe Lancet. Infectious diseases2015

Human infection with a novel tick-borne Anaplasma species in China: a surveillance study.

Hao Li, Yuan-Chun Zheng, Lan Ma, Na Jia, Bao-Gui Jiang, Rui-Ruo Jiang, Qiu-Bo Huo, Ya-Wei Wang, Hong-Bo Liu, Yan-Li Chu and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Article
  8. Genetic Diversity and Novel Lineages ofPathogens (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in cellular and infection microbiology · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Hao LiState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Yuan-Chun ZhengMudanjiang Forestry Central Hospital, Mudanjiang, Heilongjiang Province, China.
Lan MaState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Na JiaState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Bao-Gui JiangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Rui-Ruo JiangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Qiu-Bo HuoMudanjiang Forestry Central Hospital, Mudanjiang, Heilongjiang Province, China.
Ya-Wei WangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Hong-Bo LiuState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Yan-Li ChuMudanjiang Forestry Central Hospital, Mudanjiang, Heilongjiang Province, China.
Yu-Dong SongMudanjiang Forestry Central Hospital, Mudanjiang, Heilongjiang Province, China.
Nan-Nan YaoMudanjiang Forestry Central Hospital, Mudanjiang, Heilongjiang Province, China.
Tie SunMudanjiang Forestry Central Hospital, Mudanjiang, Heilongjiang Province, China.
Fan-Yi ZengShanghai Institute of Medical Genetics, Shanghai Jiaotong University, Shanghai, China.
J Stephen DumlerDepartments of Pathology and Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Jia-Fu JiangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Wu-Chun CaoState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China. Electronic address: caowc@bmi.ac.cn.

Funding

EHRLICHIA-GRANULOCYTE INTERACTIONS AND INFECTIONR01AI044102 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DUMLER, JOHN STEPHEN · 2000 to 2019
$5.3M
NIAID NIH HHS R01 AI044102
6 · The paper itself

Abstract

backgroundAnaplasma phagocytophilum and Anaplasma ovis cause human infections. We investigated the potential for human pathogenicity of a newly discovered Anaplasma species infecting goats in China.

methodsWe collected blood samples from patients with a history of tick bite in the preceding 2 months at Mudanjiang Forestry Central Hospital of Heilongjiang Province from May 1, to June 10, 2014, to detect the novel Anaplasma species by PCR. We inoculated positive samples into cell cultures. We characterised the isolated pathogen by morphological and phylogenetic analyses. We tested serum antibodies by indirect immunofluorescence assay.

findings28 (6%) of 477 patients assessed were infected with the novel Anaplasma species according to PCR and sequencing. We isolated the pathogen in vitro from three patients. Phylogenetic analyses of rrs, gltA, groEL, msp2, and msp4 showed that the pathogen was distinct from all known Anaplasma species. We provisionally nominate it "Anaplasma capra". 22 (92%) of 24 patients with data available had seroconversion or a four-fold increase in antibody titres. All 28 patients developed non-specific febrile manifestations, including fever in 23 (82%), headache in 14 (50%), malaise in 13 (46%), dizziness in nine (32%), myalgia in four (14%), and chills in four (14%). Additionally, ten (36%) of 28 patients had rash or eschar, eight (29%) had lymphadenopathy, eight (29%) had gastrointestinal symptoms, and three (11%) had stiff neck. Five patients were admitted to hospital because of severe disease. Six (35%) of 17 patients with data available had high hepatic aminotransferase concentrations.

interpretationThe emergence of "A capra" as a cause of human disease suggests that individuals living in or travelling to endemic regions in northern China should take precautions to reduce their risk of exposure to this novel tick-borne pathogen.

fundingNatural Science Foundation of China and the US National Institutes of Health.

Indexed as

AdolescentAdultAgedAnaplasmaAnimalsCell Culture TechniquesChildChinaEhrlichiosisEpidemiological MonitoringFemaleHumansMaleMiddle AgedPhylogenyPolymerase Chain Reaction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.